EDUARDO YABUT: Open Payments
NPI 1457395691 · JAMESTOWN, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 13 payments from 7 companies in 2025. Trend: 2023 $365 · 2024 $333 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: ABILIFY ASIMTUFII, INGREZZA, TRINTELLIX, FANAPT, UZEDY, ARISTADA, COBENFY.
Industry payments across ND — which companies pay providers there.
